The event witnessed more than 35 participants from various top organizations and positions including CEOs, budding startup entrepreneurs, investors, policy makers and directors.
In the back drop of the recent budget execution by Finance Minister Arun Jaitley in February 2015, the conclave opened wide doors for an engaging and stimulating discussion on the impact of the budget on the industry.
Hosted by Mr Narayanan Suresh, group editor, BioSpectrum India & Asia, the forum offered a open setting for participants to express their view point, expectations, concerns and issues impacting the industry.
Issues relating to tax payments and incentives, SME growth, innovation insurance, funding, government-industry collaboration, and clinical research dominated the discussion forum.
Dr Mahadevappa, director, JSS Rural Development Foundation, opined, "It is a critical time that the government should come forward and exploit the potential. There are opportunities where without spending money farmers can derive benefits."
Ecron Acunova's chairman, Mr D A Prasanna pointed that one of the major hurdles to ‘Make in India' is the unsynchronized coordination between the Department of Pharmaceuticals, Department of Biotechnology and Department of Health.